Search results (8)
« Back to NewsLatest research news and updates
New study shows ivermectin lacks meaningful benefits in COVID-19 treatment
13 March 2024
New research led by the University of Oxford has concluded that the antiparasitic drug ivermectin does not provide clinically meaningful benefits for treating COVID-19 in a largely vaccinated population.
Findings into colchicine published in the British Journal of General Practice
19 April 2022
Findings from research by the PRINCIPLE Trial into treatment of COVID-19 in the community with the anti-inflammatory drug colchicine published in the British Journal of General Practice.
PRINCIPLE Trial calls on UK primary care to support patient recruitment
22 June 2020
The Co-Chief Investigators of the PRINCIPLE Trial, Professor Chris Butler and Professor Richard Hobbs, write an open letter to health professionals across UK primary care calling on their support, so those who are still contracting COVID-19 are given the opportunity to join the trial.
National priority COVID-19 trial recruits first patients
17 April 2020
Researchers from Oxford University are now enrolling participants into PRINCIPLE, the first clinical trial of potential COVID-19 treatments to take place in GP practices.
GP practices urged to join COVID-19 research
30 March 2020
The Nuffield Department of Primary Care Health Sciences at the University of Oxford and the Royal College of General Practitioners (RCGP) have joined forces with clinical system supplier EMIS Health to urgently recruit as many GP practices as possible for COVID-19 research.